https://www.avdailynews.com/single-post/2019/06/22/the-fda-approves-drug-for-loss-of-female-sexual-desire
The FDA approves drug for loss of female sexual desire.
Jun 22, 2019 - The U.S. Food and Drug Administration approved Vyleesi (bremelanotide) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal...
female sexual desirefdaapprovesdrugloss
https://pmc.ncbi.nlm.nih.gov/articles/PMC7731354/
Interactions between inflammation and female sexual desire and arousal function - PMC
To describe the current state of research on interactions between inflammation and female sexual function. Inflammation may interfere with female sexual desire...
female sexual desireinteractionsinflammationarousalfunction